Line 54: | Line 54: | ||
<h3>Koi pond inside our school|May 17th, 2019</h3><br/> | <h3>Koi pond inside our school|May 17th, 2019</h3><br/> | ||
− | <h4> | + | <h3>Identifying Problems & Developing Solutions.<h3><h4> Our iGEM project inspiration came from one chance event at our own school’s Koi pond. The first person we decided would be a great resource of information about potential problems we could identify begin to develop synthetic biology solutions to was our school head of operations Mr. Wang. We reached out to him early in our project developing as we felt he could give us the first-hand information about Koi breeding and health issues associated with them. We asked Mr. Wang specifically about the pond maintenance, the relevant cost of running the pond and of raising the (such as cost of fish food and drugs),. We also asked about the mortality rate of fish and whether the fish are getting any kind of treatments to help their health or indeed even on a vaccination program.</h4> <br><h4>According to Mr. Wang, they feed fish every morning with fish food that containing amylose and lecithin in the ingredients that will boost the fish immune system. They also clean the pond every 2-3 months to keep the water clean, tgis was after the early years when the mortality rate of fish was high, but importunely he could not tell us what exact disease the fish were getting. In the first few years, the school spends 3000-4000 RMB per year on purchasing new fish due needed to replace the fish which die throughout the year. According to Mr. Wang, in 2017 the mortality rate of the fish was very high that they had to spend almost 3 times money on purchasing new fish than regular years. Again it was unclear what disease caused this problem as Mr. Wang tells told us the koi they buy is at the lower end of the market and are very common so are not the sought after expensive breeds.</h4><br> |
+ | <h4>When we asked Mr. Wang if they vaccinate the fish against any disease, the answer was no. The Koi the school purchased were the cheap ones, so they think the fish food that containing the immune system boost ingredient will be enough for our Koi. The fish themselves are also not vaccinated against anything prior to purchasing. </h4><br/> | ||
+ | |||
Revision as of 23:30, 21 October 2019
Human Practice
Introduction
Our project’s focus was on the development of engineered bacterial strains which could act as vaccine delivery systems by expressing recombinant genes. Our long term goal would be to have a positive impact of on the aquaculture and fisheries industries, more specifically, the high end and mid level ornamental fish industry which breed varieties of koi fish (Cyprinus rubrofuscus). Our final engineered designs we worked so hard on were designed to be capable of providing these high value fish varieties immunity against the Cyprinid herpes virus-3, which cases the high mortality rate disease Koi herpesvirus disease (KHVD).
As always the design of a genetically engineered system requires many revisions, multiple identification of new problems, and several development of potential solutions all of which needed to be informed by good science and have logical reasoning for pursuing. In this sense, each stage of our project since the early team meetings of our BioBuilder club have been informed by the individuals and organizations we sought out and contacted, in order to ensure we had a safe, consequential, interesting, and scientifically sound project. This section outlines our efforts in that endeavor.
The goals of our integrated Human Practices work can be summarized in the following points:
1. We wanted to first learn what were the issues associated with the koi fish industry and more specifically to see what a potential problems exists that could be solved, or at least improved, with synthetic biology concepts. This was our generating ideas and identifying problems part of the engineering design process.
2. We then wanted advice on the early stages of our genetically engineered systems. Here we sought academic experts that have worked on the health of fish in aquaculture and precisely the health and breeding of Koi. The ideas generated we had at this stage were based on discussion among ourselves and from a review of the associated literature. We were able to discuss in detail our potential solutions with professors and bring back more ideas for the refinement stage of our project design.
3. Once we developed our idea and design to an advanced stage we wanted to seek out people within the fish feed and drug industry, as these people are also experts in the final product for therapeutics relating to aquaculture. At this stage we had identified new problems that needed overcoming and got valuable insight from these people on the methods used to deliver such medicines and biomolecules to fish. We also gained insight into the business side of things and how we could possibly eventually develop our idea into a marketable product should any trails we performed prove successful.